biotech / news / / The Irish Times
Dilek Dogan Gurluk chosen as The Irish Times Business Person of the Month.
Novo Nordisk will invest €432 million to upgrade its Athlone plant for Wegovy tablet production.
KEY POINTS
- The Athlone plant, acquired for €85 million in 2024, will serve markets outside the United States.
- Construction on the Athlone upgrade has already begun, with completion expected in 2028.
- Novo Nordisk produces the Wegovy obesity pill for the U.S. market exclusively within the United States.
COMPANIES
Summarized by Newsio from The Irish Times. How we summarize →